Table of Content

1 Prophylactic HIV Drug Market Overview
1.1 Product Overview and Scope of Prophylactic HIV Drug
1.2 Prophylactic HIV Drug Segment by Type
1.2.1 Global Prophylactic HIV Drug Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI)
1.2.3 Integrase Inhibitor
1.3 Prophylactic HIV Drug Segment by Application
1.3.1 Prophylactic HIV Drug Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Prophylactic HIV Drug Market Size Estimates and Forecasts
1.4.1 Global Prophylactic HIV Drug Revenue 2016-2027
1.4.2 Global Prophylactic HIV Drug Sales 2016-2027
1.4.3 Prophylactic HIV Drug Market Size by Region: 2016 Versus 2021 Versus 2027

2 Prophylactic HIV Drug Market Competition by Manufacturers
2.1 Global Prophylactic HIV Drug Sales Market Share by Manufacturers (2016-2021)
2.2 Global Prophylactic HIV Drug Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Prophylactic HIV Drug Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Prophylactic HIV Drug Manufacturing Sites, Area Served, Product Type
2.5 Prophylactic HIV Drug Market Competitive Situation and Trends
2.5.1 Prophylactic HIV Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Prophylactic HIV Drug Players Market Share by Revenue
2.5.3 Global Prophylactic HIV Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Prophylactic HIV Drug Retrospective Market Scenario by Region
3.1 Global Prophylactic HIV Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Prophylactic HIV Drug Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Prophylactic HIV Drug Market Facts & Figures by Country
3.3.1 North America Prophylactic HIV Drug Sales by Country
3.3.2 North America Prophylactic HIV Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Prophylactic HIV Drug Market Facts & Figures by Country
3.4.1 Europe Prophylactic HIV Drug Sales by Country
3.4.2 Europe Prophylactic HIV Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Prophylactic HIV Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Prophylactic HIV Drug Sales by Region
3.5.2 Asia Pacific Prophylactic HIV Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Prophylactic HIV Drug Market Facts & Figures by Country
3.6.1 Latin America Prophylactic HIV Drug Sales by Country
3.6.2 Latin America Prophylactic HIV Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Prophylactic HIV Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Prophylactic HIV Drug Sales by Country
3.7.2 Middle East and Africa Prophylactic HIV Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Prophylactic HIV Drug Historic Market Analysis by Type
4.1 Global Prophylactic HIV Drug Sales Market Share by Type (2016-2021)
4.2 Global Prophylactic HIV Drug Revenue Market Share by Type (2016-2021)
4.3 Global Prophylactic HIV Drug Price by Type (2016-2021)

5 Global Prophylactic HIV Drug Historic Market Analysis by Application
5.1 Global Prophylactic HIV Drug Sales Market Share by Application (2016-2021)
5.2 Global Prophylactic HIV Drug Revenue Market Share by Application (2016-2021)
5.3 Global Prophylactic HIV Drug Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Gilead Sciences
6.1.1 Gilead Sciences Corporation Information
6.1.2 Gilead Sciences Description and Business Overview
6.1.3 Gilead Sciences Prophylactic HIV Drug Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Gilead Sciences Product Portfolio
6.1.5 Gilead Sciences Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Prophylactic HIV Drug Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Merck Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Prophylactic HIV Drug Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Mylan Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Cipla
6.4.1 Cipla Corporation Information
6.4.2 Cipla Description and Business Overview
6.4.3 Cipla Prophylactic HIV Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Cipla Product Portfolio
6.4.5 Cipla Recent Developments/Updates
6.5 Bristol-Myers Squibb
6.5.1 Bristol-Myers Squibb Corporation Information
6.5.2 Bristol-Myers Squibb Description and Business Overview
6.5.3 Bristol-Myers Squibb Prophylactic HIV Drug Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Bristol-Myers Squibb Product Portfolio
6.5.5 Bristol-Myers Squibb Recent Developments/Updates
6.6 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Prophylactic HIV Drug Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Roche Product Portfolio
6.6.5 Roche Recent Developments/Updates

7 Prophylactic HIV Drug Manufacturing Cost Analysis
7.1 Prophylactic HIV Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Prophylactic HIV Drug
7.4 Prophylactic HIV Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Prophylactic HIV Drug Distributors List
8.3 Prophylactic HIV Drug Customers

9 Prophylactic HIV Drug Market Dynamics
9.1 Prophylactic HIV Drug Industry Trends
9.2 Prophylactic HIV Drug Growth Drivers
9.3 Prophylactic HIV Drug Market Challenges
9.4 Prophylactic HIV Drug Market Restraints

10 Global Market Forecast
10.1 Prophylactic HIV Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Prophylactic HIV Drug by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Prophylactic HIV Drug by Type (2022-2027)
10.2 Prophylactic HIV Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Prophylactic HIV Drug by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Prophylactic HIV Drug by Application (2022-2027)
10.3 Prophylactic HIV Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Prophylactic HIV Drug by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Prophylactic HIV Drug by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Prophylactic HIV Drug Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Prophylactic HIV Drug Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Prophylactic HIV Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Prophylactic HIV Drug Covered in This Study
Table 5. Global Prophylactic HIV Drug Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Prophylactic HIV Drug Sales Share by Manufacturers (2016-2021)
Table 7. Global Prophylactic HIV Drug Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Prophylactic HIV Drug Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Prophylactic HIV Drug Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Prophylactic HIV Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Prophylactic HIV Drug Product Type
Table 12. Global Prophylactic HIV Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Prophylactic HIV Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prophylactic HIV Drug as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Prophylactic HIV Drug Sales by Region (2016-2021) & (K Units)
Table 16. Global Prophylactic HIV Drug Sales Market Share by Region (2016-2021)
Table 17. Global Prophylactic HIV Drug Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Prophylactic HIV Drug Sales by Country (2016-2021) & (K Units)
Table 19. North America Prophylactic HIV Drug Sales Market Share by Country (2016-2021)
Table 20. North America Prophylactic HIV Drug Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Prophylactic HIV Drug Revenue Market Share by Country (2016-2021)
Table 22. Europe Prophylactic HIV Drug Sales by Country (2016-2021) & (K Units)
Table 23. Europe Prophylactic HIV Drug Sales Market Share by Country (2016-2021)
Table 24. Europe Prophylactic HIV Drug Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Prophylactic HIV Drug Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Prophylactic HIV Drug Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Prophylactic HIV Drug Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Prophylactic HIV Drug Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Prophylactic HIV Drug Revenue Market Share by Region (2016-2021)
Table 30. Latin America Prophylactic HIV Drug Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Prophylactic HIV Drug Sales Market Share by Country (2016-2021)
Table 32. Latin America Prophylactic HIV Drug Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Prophylactic HIV Drug Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Prophylactic HIV Drug Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Prophylactic HIV Drug Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Prophylactic HIV Drug Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Prophylactic HIV Drug Revenue Market Share by Country (2016-2021)
Table 38. Global Prophylactic HIV Drug Sales (K Units) by Type (2016-2021)
Table 39. Global Prophylactic HIV Drug Sales Market Share by Type (2016-2021)
Table 40. Global Prophylactic HIV Drug Revenue (Million US$) by Type (2016-2021)
Table 41. Global Prophylactic HIV Drug Revenue Share by Type (2016-2021)
Table 42. Global Prophylactic HIV Drug Price (USD/Unit) by Type (2016-2021)
Table 43. Global Prophylactic HIV Drug Sales (K Units) by Application (2016-2021)
Table 44. Global Prophylactic HIV Drug Sales Market Share by Application (2016-2021)
Table 45. Global Prophylactic HIV Drug Revenue (Million US$) by Application (2016-2021)
Table 46. Global Prophylactic HIV Drug Revenue Share by Application (2016-2021)
Table 47. Global Prophylactic HIV Drug Price (USD/Unit) by Application (2016-2021)
Table 48. Gilead Sciences Corporation Information
Table 49. Gilead Sciences Description and Business Overview
Table 50. Gilead Sciences Prophylactic HIV Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Gilead Sciences Prophylactic HIV Drug Product
Table 52. Gilead Sciences Recent Developments/Updates
Table 53. Merck Corporation Information
Table 54. Merck Description and Business Overview
Table 55. Merck Prophylactic HIV Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Merck Prophylactic HIV Drug Product
Table 57. Merck Recent Developments/Updates
Table 58. Mylan Corporation Information
Table 59. Mylan Description and Business Overview
Table 60. Mylan Prophylactic HIV Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Mylan Prophylactic HIV Drug Product
Table 62. Mylan Recent Developments/Updates
Table 63. Cipla Corporation Information
Table 64. Cipla Description and Business Overview
Table 65. Cipla Prophylactic HIV Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Cipla Prophylactic HIV Drug Product
Table 67. Cipla Recent Developments/Updates
Table 68. Bristol-Myers Squibb Corporation Information
Table 69. Bristol-Myers Squibb Description and Business Overview
Table 70. Bristol-Myers Squibb Prophylactic HIV Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Bristol-Myers Squibb Prophylactic HIV Drug Product
Table 72. Bristol-Myers Squibb Recent Developments/Updates
Table 73. Roche Corporation Information
Table 74. Roche Description and Business Overview
Table 75. Roche Prophylactic HIV Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Roche Prophylactic HIV Drug Product
Table 77. Roche Recent Developments/Updates
Table 78. Production Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Prophylactic HIV Drug Distributors List
Table 81. Prophylactic HIV Drug Customers List
Table 82. Prophylactic HIV Drug Market Trends
Table 83. Prophylactic HIV Drug Growth Drivers
Table 84. Prophylactic HIV Drug Market Restraints
Table 85. Global Prophylactic HIV Drug Sales Forecast by Type (2022-2027) & (K Units)
Table 86. Global Prophylactic HIV Drug Sales Market Share Forecast by Type (2022-2027)
Table 87. Global Prophylactic HIV Drug Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 88. Global Prophylactic HIV Drug Revenue Market Share Forecast by Type (2022-2027)
Table 89. Global Prophylactic HIV Drug Sales Forecast by Application (2022-2027) & (K Units)
Table 90. Global Prophylactic HIV Drug Sales Market Share Forecast by Application (2022-2027)
Table 91. Global Prophylactic HIV Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 92. Global Prophylactic HIV Drug Revenue Market Share Forecast by Application (2022-2027)
Table 93. Global Prophylactic HIV Drug Sales Forecast by Region (2022-2027) & (K Units)
Table 94. Global Prophylactic HIV Drug Sales Market Share Forecast by Region (2022-2027)
Table 95. Global Prophylactic HIV Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 96. Global Prophylactic HIV Drug Revenue Market Share Forecast by Region (2022-2027)
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Prophylactic HIV Drug
Figure 2. Global Prophylactic HIV Drug Market Share by Type in 2020 & 2027
Figure 3. Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI) Product Picture
Figure 4. Integrase Inhibitor Product Picture
Figure 5. Global Prophylactic HIV Drug Market Share by Application in 2020 & 2027
Figure 6. Hospital Pharmacy
Figure 7. Retail Pharmacy
Figure 8. Online Pharmacy
Figure 9. Global Prophylactic HIV Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Prophylactic HIV Drug Market Size 2016-2027 (US$ Million)
Figure 11. Global Prophylactic HIV Drug Sales 2016-2027 (K Units)
Figure 12. Global Prophylactic HIV Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Prophylactic HIV Drug Sales Share by Manufacturers in 2020
Figure 14. Global Prophylactic HIV Drug Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Prophylactic HIV Drug Players: Market Share by Revenue in 2020
Figure 16. Prophylactic HIV Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Prophylactic HIV Drug Sales Market Share by Region (2016-2021)
Figure 18. Global Prophylactic HIV Drug Sales Market Share by Region in 2020
Figure 19. Global Prophylactic HIV Drug Revenue Market Share by Region (2016-2021)
Figure 20. Global Prophylactic HIV Drug Revenue Market Share by Region in 2020
Figure 21. U.S. Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Prophylactic HIV Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Prophylactic HIV Drug by Type (2016-2021)
Figure 46. Sales Market Share of Prophylactic HIV Drug by Application (2016-2021)
Figure 47. Sales Market Share of Prophylactic HIV Drug by Application in 2020
Figure 48. Revenue Share of Prophylactic HIV Drug by Application (2016-2021)
Figure 49. Revenue Share of Prophylactic HIV Drug by Application in 2020
Figure 50. Manufacturing Cost Structure of Prophylactic HIV Drug
Figure 51. Manufacturing Process Analysis of Prophylactic HIV Drug
Figure 52. Prophylactic HIV Drug Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed